Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Total Liabilities (2016 - 2025)

Bio-Techne has reported Total Liabilities over the past 17 years, most recently at $511.7 million for Q4 2025.

  • Quarterly results put Total Liabilities at $511.7 million for Q4 2025, down 13.55% from a year ago — trailing twelve months through Dec 2025 was $511.7 million (down 13.55% YoY), and the annual figure for FY2025 was $639.1 million, up 0.64%.
  • Total Liabilities for Q4 2025 was $511.7 million at Bio-Techne, down from $560.3 million in the prior quarter.
  • Over the last five years, Total Liabilities for TECH hit a ceiling of $767.2 million in Q4 2023 and a floor of $511.7 million in Q4 2025.
  • Median Total Liabilities over the past 5 years was $612.8 million (2021), compared with a mean of $627.3 million.
  • Biggest five-year swings in Total Liabilities: decreased 24.17% in 2021 and later surged 43.05% in 2023.
  • Bio-Techne's Total Liabilities stood at $602.3 million in 2021, then dropped by 10.96% to $536.3 million in 2022, then surged by 43.05% to $767.2 million in 2023, then fell by 22.84% to $591.9 million in 2024, then dropped by 13.55% to $511.7 million in 2025.
  • The last three reported values for Total Liabilities were $511.7 million (Q4 2025), $560.3 million (Q3 2025), and $639.1 million (Q2 2025) per Business Quant data.